Craft

Virometix

Total Funding

$18.5 M

Virometix Summary

Company Summary

Overview
Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. It specializes in respiratory syncytial virus (RSV), universal pneumococcal, coronaviruses, and cancer vaccines.
Type
Private
Status
Active
Founded
2009
HQ
Schlieren, CH | view all locations
Website
https://www.virometix.com/
Cybersecurity rating
Sectors

Key People

  • Anna Sumeray

    Anna Sumeray, Chief Executive Officer, Director

  • Harry Welten, Chairman

    • Lilli Stergiou

      Lilli Stergiou, Chief Scientific Officer

    • Sasan Navid, Chief Financial Officer

      Operating MetricsView all

      Countries

      13

      Jun, 2023

      Languages

      4

      Jun, 2023

      Awards

      5

      Jun, 2023

      LocationsView all

      1 location detected

      • Schlieren, ZH HQ

        Switzerland

        Wagistrasse 14

      Footer menu